20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T67737 | gp120-α4β7 binding inhibitor 11 | HIV Protease | |
gp120-α4β7 binding inhibitor 11 is an anti-HIV agent. gp120-α4β7 binding inhibitor 11 interferes the binding of HIV associated glycoprotein gp12G with the integrin α4β7 (IC50=1.64nM). | |||
T60714 | gp120-IN-2 | ||
gp120-IN-2 (compound 4i) exhibits anti-HIV-1 activity which is a potent inhibitor of HIV-1 gp120 with an IC 50 of 7.5 μM and CC 50 of 112.93 μM. gp120-IN-2 dose-dependently shows cytotoxicity in SUP-T1 cells [1]. | |||
T60871 | gp120-IN-1 | ||
gp120-IN-1 (compound 4e) is a potent HIV-1 gp120 inhibitor with an CC 50 of 100.90 μM and IC 50 of 2.2 μM. gp120-IN-1 inhibitis gp120-mediated virus enter into cells. gp120-IN-1 has anti-HIV-1 activity. gp120-IN-1 has do... | |||
T76537 | GP120, HIV-1 MN | ||
GP120, HIV-1 MN, a peptide, is utilized in researching HIV infection [1] [2]. | |||
T16276 | NBD-556 | HIV Protease | |
NBD-556 is a small molecule mimetic of CD4. NBD-556 recognizes the HIV-1 envelope protein gp120 and induces restructuring of gp120 analogous to CD4 binding. | |||
T6418 | BMS-378806 | BMS378806,BMS-806 | gp120/CD4 , HIV Protease |
BMS-378806 (BMS-806) selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus. | |||
T4665 | Temsavir | BMS626529 | HIV Protease |
Temsavir (BMS626529) is a novel attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells. | |||
TP1785L | Peptide T acetate(106362-32-7 free base) | Others , HIV Protease | |
Peptide T acetate is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a synthetic octapeptide whose possible mechanism of action is the competitive inhibition of gp120 to the CD4 receptor as well as binding... | |||
T71665 | INCB-9471 | HIV Protease , CCR | |
INCB-9471 is a CCR5 antagonist with anti-HIV activity and inhibits the interaction between HIV-1 gp120. | |||
T10570 | Fostemsavir Tris | BMS-663068 Tris | HIV Protease |
Fostemsavir Tris (BMS-663068 Tris) is the prodrug of BMS-626529,is a oral, safe and effective inhibitor of HIV-1 attachment. It inhibits human immunodeficiency virus type 1 (HIV-1) infection by binding to gp120 and inter... | |||
T3523 | Fostemsavir | BMS-663068 | HIV Protease |
Fostemsavir (BMS-663068) is an HIV-1 attachment inhibitor in development for the treatment of HIV-1 infection. | |||
T80580 | Zinlirvimab | 10-1074 | |
Zinlirvimab is a humanized IgG1-λ2 monoclonal antibody that neutralizes HIV by targeting the HIV-1 gp120 envelope glycoprotein, specifically the IIIB gp120 V3 loop [1] [2]. | |||
T23108 | Ophiobolin C | Others | |
inhibitor of human CCR5 binding to HIV-1 gp120 | |||
T69371 | BMS 378806 | ||
BMS-378806 is an orally bioavailable HIV-1 inhibitor that interferes with gp120-CD4 interaction. | |||
TP2401 | Peptide T amide | D-Ala(1)-peptide T amide | |
Peptide T amide is an octapeptide segment of HIV envelope gp120 and is used in AIDS therapy. | |||
T30532 | BMS-585248 | CHEMBL236995,CIO2TZZ9H1,BMS 585248,UNII-CIO2TZZ9H1 | |
BMS-585248 is a highly effective HIV-1 adhesion inhibitor that targets the viral envelope protein gp120. | |||
T72099 | Carbomethoxycarbonyl-D-Pro-D-Phe-OBzl | ||
Carbomethoxycarbonyl-D-Pro-D-Phe-OBzl is an HIV-1 inhibitor that functions by interacting with gp120, thereby preventing its binding to CD4. This mechanism helps to maintain CD4-dependent T cell function. | |||
TP1785 | Peptide T | ||
Peptide T is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a synthetic octapeptide whose possible mechanism of action is the competitive inhibition of gp120 to the CD4 receptor as well as binding to vaso... | |||
T71094 | CD4 (81-92) | ||
CD4 (81-92) is a peptide that was previously found to inhibit gp120 binding, HIV-1 infectivity, and syncytium formation. | |||
T7624 | DAPTA | DAPTA(TFA),D-Ala-peptide T-amide,Adaptavir | HIV Protease , CCR |
DAPTA (Adaptavir) is an inhibitor of CCR5, shows potent anti-HIV activities. |